Fokus Nephrologie
暂无分享,去创建一个
C. Beynon | M. Weigand | T. Brenner | C. Reuß | M. Bernhard | A. Hecker | C. Jungk | C. Nusshag | D. Michalski | M. Dietrich | M. Fiedler
[1] S. Besset,et al. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial , 2021, The Lancet.
[2] M. Zeier,et al. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study , 2019, Critical care medicine.
[3] D. Annane,et al. Timing of Renal‐Replacement Therapy in Patients with Acute Kidney Injury and Sepsis , 2018, The New England journal of medicine.
[4] J. Vincent,et al. A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit , 2018, Critical Care.
[5] J. Kellum,et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. , 2016, JAMA.
[6] F. Tubach,et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. , 2016, The New England journal of medicine.
[7] N. Fealy. Regional Citrate Anticoagulation , 2016 .
[8] R. Bellomo,et al. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults* , 2015, Critical care medicine.
[9] Rinaldo Bellomo,et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study , 2015, Intensive Care Medicine.
[10] P. Kimmel,et al. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. , 2015, Journal of the American Society of Nephrology : JASN.
[11] A. Girbes,et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial , 2014, Critical Care.
[12] A. Kribben,et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] R. Bellomo,et al. Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.